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Department of Biochemistry, University of Oxford, Oxford, United KingdomABSTRACT Phosphatase and tensin-homolog deleted on chromosome 10 (PTEN) is a tumor-suppressor protein that
regulates phosphatidylinositol 3-kinase (PI3-K) signaling by binding to the plasma membrane and hydrolyzing the 30 phosphate
from phosphatidylinositol (3,4,5)-trisphosphate (PI(3,4,5)P3) to form phosphatidylinositol (4,5)-bisphosphate (PI(4,5)P2).
Several loss-of-function mutations in PTEN that impair lipid phosphatase activity and membrane binding are oncogenic, leading
to the development of a variety of cancers, but information about the membrane-associated state of PTEN remains sparse. We
have modeled a membrane-associated state of the truncated PTEN structure bound to PI(3,4,5)P3 via multiscale molecular
dynamics simulations. We show that the location of the membrane-binding surface agrees with experimental observations
and is robust to changes in lipid composition. The level of membrane interaction is substantially reduced in the phosphatase
domain for the triple mutant R161E/K163E/K164E, in line with experimental results. We observe clustering of anionic lipids
around the C2 domain in preference to the phosphatase domain, suggesting that the C2 domain is involved in nonspecific inter-
actions with negatively charged lipid headgroups. Finally, our simulations suggest that the oncogenicity of the R335L mutation
may be due to a reduction in the interaction of the mutant PTEN with anionic lipids.INTRODUCTIONCell signaling involves a number of proteins that interact
with cell membranes. Several such proteins bind to the inner
(cytoplasmic) surface of the plasma membrane to carry out
their function. To facilitate this, many of these proteins
possess one or more distinct lipid binding domains. Several
of these lipid-binding domains have been identified (1),
and they typically exploit the presence of anionic lipids in
the plasma membrane to target proteins to the surface via
electrostatic interactions (2,3). While estimates vary, the
concentration of anionic lipids (of various species) in the
cytoplasmic leaflet of the cell membrane is thought to be
between 10 and 20% depending on the cell type (4–7).
These anionic lipids play two roles in protein targeting:
First, the pool of negatively charged lipids allows for
recruitment of positively charged lipid-binding domains
through nonspecific interactions with this charged surface.
Second, some species of negatively charged lipid within
this pool—for example, the phosphoinositides—can act as
specific recognition sites for particular protein domains
(8,9).
The plasma membrane and its constituent phosphoinosi-
tides form the basis of the phosphatidylinositol 3-kinase
(PI3-K) signaling pathway, which is crucial for cell prolifer-Submitted September 11, 2012, and accepted for publication December 4,
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upon two lipid species, phosphatidylinositol (4,5)-bisphos-
phate (PI(4,5)P2) and phosphatidylinositol (3,4,5)-trisphos-
phate (PI(3,4,5)P3), which are differentiated by the
presence or absence of a phosphate group at the 30 position
of the inositol ring (9). Activation of PI3-K signaling is
dependent upon biosynthesis of PI(3,4,5)P3 from PI(4,5)P2
by the PI3-K enzyme. The newly synthesized PI(3,4,5)P3
can then provide a membrane anchor to recruit other
proteins to the surface, for example Akt (protein kinase B)
that binds PI(3,4,5)P3 through its pleckstrin homology
(PH) domain. Akt is an essential downstream effector in
PI3-K signaling (11) that regulates cell proliferation and
survival by inhibiting apoptosis.
Membrane localization via PI(3,4,5)P3 binding is essen-
tial for Akt activation, and so any factors that enhance Akt
binding to PI(3,4,5)P3 can result in pathological membrane
localization and, by extension, uncontrolled activation of
Akt. This in turn leads to overall dysregulation of PI3-K
signaling and has been linked to the development of several
cancers. Pathological membrane localization can be caused
by a mutation in Akt itself (12), or alternatively it can occur
as a consequence of elevated levels of PI(3,4,5)P3. Produc-
tion of PI(3,4,5)P3 is normally regulated by the phosphatase
and tensin homolog deleted on chromosome 10 (PTEN)
tumor suppressor protein, which negatively regulates
PI3-K signaling by converting PI(3,4,5)P3 back to PI(4,5)
P2, thereby keeping the basal level of PI(3,4,5)P3 low
(13,14) However, loss-of-function mutations in PTEN can
lead to overproduction of PI(3,4,5)P3 and uncontrolled
PI3-K activation. PTEN is one of the most frequently
mutated proteins in human cancer (15). Consequently, therehttp://dx.doi.org/10.1016/j.bpj.2012.12.002
614 Lumb and Sansomis a wealth of mutational data available, as summarized in
the Human Gene Mutation Database (16).
The full-length PTEN protein comprises ~400 amino
acid residues and is subdivided into four main regions: an
N-terminal PI(4,5)P2 binding module; a phosphatase
domain (PD); a C2 domain; and a C-terminal tail (Fig. 1).
A crystal structure of truncated PTEN at 2.1 A˚ that includes
the PD and the C2 domain has previously been determined
(PDB:1D5R (17); see Fig. 1). However, although PTEN is
a key component of PI3-K signaling, little is known about
its mode of interaction with the plasma membrane.FIGURE 1 Structure of PTEN. (A) Domain structure of PTEN. (B) The
crystal structure of PTEN, with the phosphatase domain (PD; residues
14–185) in pink and the C2 domain (residues 186–351) in cyan. The tartrate
molecule bound in the phosphatase active site is shown as van der Waals
spheres. The loop missing from the crystal structure between P281 and
K313 is shown as a dotted line. (C) Coarse-grained (CG) representation
of PTEN. The bound tartrate has been replaced with a CG representation
of PI(3,4,5)P3, with the PI(3,4,5)P3 molecule positioned as described in
the main text.
Biophysical Journal 104(3) 613–621Molecular dynamics (MD) simulations provide us with a
computational tool to probe the interaction between mem-
brane proteins and the lipid bilayer in near-atomic detail
(18). There have been a number of MD simulation studies
concerning the interactions of C2 (19–21) and other (22–
24) lipid-recognizing domains with membrane surfaces. In
recent studies of the membrane interaction of the PH
domain from the general receptor for phosphoinositides 1
(GRP1-PH) (25) and talin (26), the specific protein-lipid
contacts revealed by MD simulations have been shown to
be in good agreement with experimental results.
Here we use a multiscale approach, combining coarse-
grained (CG) and atomistic MD simulations (27), to develop
a model of the PTEN-membrane complex. This allows us
to analyze the nature of PTEN-membrane interactions,
revealing the importance of anionic phospholipids in inter-
actions with the C2 domain of PTEN. A number of
disease-related mutations of PTEN are shown to be likely
to perturb interactions between this important protein and
the plasma membrane surface.MATERIALS AND METHODS
Model building and system setup
Our studies of membrane-bound PTEN started from the crystal structure
of PTEN (PDB:1D5R (17)), which comprises the two core domains of
PTEN: a phosphatase domain (PD), and a C2 domain with a missing region
between residues 281 and 313 of the C2 domain (Fig. 1). In the atomistic
simulations, a harmonic restraint with spring constant 100 pN/A˚was placed
between the Ca atoms of P281 and K313 to maintain the separation
observed in the crystal structure. This was judged to be a more conservative
approach than trying to model a missing loop of ~30 residues. In the CG
simulations, an elastic network model is employed to maintain the
secondary structure and so this additional restraint was not required.
The protein was crystallized in the presence of tartrate, and a tartrate
molecule is bound at the active site. The authors of the article in which
the structure was reported observed that the separation between the two
carboxylate carbon atoms of the tartrate molecule is approximately the
same as that between the phosphorus atoms at the 30 and 40 positions of
the inositol ring of PI(3,4,5)P3. We were guided by these geometric consid-
erations when constructing our initial coarse-grained (CG) model of
PI(3,4,5)P3-bound PTEN, positioning the CG phosphate particles at the
coordinates of the carboxylate carbons (Fig. 1).
All MD simulations were carried out using GROMACS version
4.0.5 (28).CG MD simulations
We conducted CG self-assembly simulations of 0.5 ms duration and subse-
quent atomistic simulations of 50 ns duration. Each CG simulation was
repeated twice using different initial particle velocities, for a total of three
simulations per system. Each CG system comprised ~300 lipids and
~10,000 water particles with monovalent ions added as appropriate to
compensate for any net charge, leaving the system neutral overall. CG
simulations were performed using the MARTINI force field (29,30). In
MARTINI, zwitterionic lipids such as POPC are approximated by a posi-
tively charged particle (choline), a negatively charged particle (phosphate),
two polar particles (glycerol), and two acyl chains made up of four and five
hydrophobic particles, respectively. Anionic lipids such as POPS are treated
PTEN Simulations 615in a similar fashion except that the positively charged particle is replaced
with a polar particle to represent the switch from choline to serine.
The lipid headgroup then carries an overall net negative charge. A cutoff
of 12 A˚ for both the Lennard-Jones and the electrostatic interactions was
used. Simulations were performed under periodic boundary conditions
and temperature was kept constant at 323 K (as in our earlier CG simula-
tions and in the MARTINI parameterization) by coupling the system to
a heat bath using a Berendsen thermostat (31) with tT ¼ 1 ps. Pressure
was maintained at 1 atm using a Parrinello-Rahman barostat (32,33) and
semiisotropic pressure coupling with tp ¼ 1 ps and a compressibility of
5  106 bar1. A timestep of Dt ¼ 0.01 ps was used, writing atomic posi-
tions every 10 ps. The neighbor list was updated every 10 steps. The final
frame of each CG simulation was converted to an atomistic representation
of the system using a fragment-based approach (27).Atomistic MD simulations
Atomistic simulations were performed with the GROMOS96 43a1 force
field (34) using the simple point charge water model (35). A cutoff of
10 A˚ was used for the Lennard-Jones interactions and electrostatic interac-
tions were treated using the particle-mesh Ewald (36) approach with
a short-range real-space cutoff of 10 A˚. Atomistic simulations were per-
formed using the same parameters as for the CG simulations, except that
T ¼ 296 K (which is above the phase transition temperatures of both
POPC and POPS; see, e.g., http://avantilipids.com), tT ¼ 0.1 ps and
compressibility was set to 4.6  105 bar1. For the atomistic simulations,
bond lengths and angles were constrained using the LINCS algorithm (37)
and a timestep of Dt ¼ 0.002 ps was used.Continuum electrostatics calculations
Electrostatic potentials were computed on a cubic grid of dimensions
129 A˚  129 A˚  129 A˚ with a grid spacing of 1 A˚ using the Adaptive
Poisson-Boltzmann Solver (38) at an anionic strength of 0.1 M and
a temperature of 300 K.Umbrella sampling and potential of mean force
calculations
Umbrella sampling CG MD simulations were performed by displacing
the PTEN protein from the surface of the bilayer by 1 A˚ intervals along
the z axis perpendicular to the plane of the membrane. Umbrella sampling
was performed by simulating each window for 0.5 ms using a restraining
potential of 100 pN/A˚ fixed at the center of mass of PTEN. The last
0.1 ms of each window was used to calculate the potential of mean force
(PMF). The PMF was computed using the g_wham tool, available as part
of the GROMACS package.RESULTS AND DISCUSSION
Simulations and the bilayer interaction of PTEN
To determine the mode of interaction of PTEN with lipid
bilayers, we used a serial combination of CG MD simula-
tions and atomistic MD simulations. To start, CG MD simu-
lations of 0.5 ms duration were used to self-assemble a lipid
bilayer around the protein and identify the location of the
membrane-binding interface. These were followed by
shorter (50 ns) atomistic simulations to probe the detailed
protein-lipid contacts in the PTEN-membrane complex
(Fig. 2). Of course, in 50 ns of atomistic simulationslarge-scale changes in protein-lipid interactions are unlikely
to occur, but such simulations enable, e.g., refinement of
sidechain-headgroup contacts formed during the initial
CG-MD simulations. Two different bilayer lipid composi-
tions were explored: either a bilayer entirely composed of
a zwitterionic lipid (phosphatidylcholine, PC; see Materials
and Methods), or a two-component bilayer formed from a
mixture of zwitterionic and anionic lipids (80% PC and
20% phosphatidylserine, PS). A set of simulations utilizing
higher concentrations of anionic lipids (60% PC and 40%
PS) was also performed (see Fig. S1 in the Supporting Mate-
rial) as a simple model of localized clustering of anionic
lipids in a cell membrane.
In all cases, a lipid bilayer formed from the initially
randomly placed lipid molecules within ~50 ns of the CG
simulation, with the PTEN molecule bound to the surface
of the bilayer. In all 15 simulations of both the wild-type
and various mutant PTEN proteins (see below and Table S1
in the Supporting Material), with different bilayer composi-
tions the same overall position and orientation of PTEN
relative to the bilayer was obtained, with the center of mass
of the protein located ~41 A˚ from the center of the bilayer
along the bilayer normal (z) axis. This places the PTENmole-
cule such that it interacts with the lipid headgroups but does
not largely penetrate the hydrophobic core of the bilayer. The
PI(3,4,5)P3 molecule modeled at the active site of the PD
domain is positioned such that its fatty acyl tails penetrate
into the hydrophobic core of the bilayer (Fig. 2 C).
The membrane-binding model predicted by this multi-
scale simulation procedure is such that the major interac-
tions between PTEN and the lipid bilayer correspond to
those regions of the protein previously suggested by exper-
iment to be most important for membrane binding, namely
the cationic patch defined by residues R161, K163, and
K164 (39), and the basic residues present in the third
Ca2þ binding region (CBR3) of the C2 domain: K260,
K263, K266, K267, and K269 (40) (Fig. 3). This further
validates our simulation approach, lending some confidence
that our model of the PTEN-membrane complex is a reason-
able approximation of the cell membrane–bound state.
PTEN is able to bind to both purely zwitterionic and
mixed zwitterionic/anionic lipid vesicles, with a higher
binding affinity for the latter (39). Comparison of residue
interactions with lipid headgroups for PTEN interactions
with PC versus PC/PS bilayers reveals that, in each case,
both the PD and C2 domains of PTEN form substantive
bilayer interactions and, for example, in the presence of
anionic lipids, the interactions between the cationic patch
and the membrane are enhanced (Fig. 3).
Mapping the lipid contacts onto the PTEN structure
reveals that the missing region in the crystal structure is
far removed from the PI(3,4,5)P3 binding site and the
proposed membrane-binding surface, and this region does
not interact with bilayer lipids during any of the simulations
(Fig. 3).Biophysical Journal 104(3) 613–621
FIGURE 2 Self-assembly and simulation of the PTEN-membrane
complex, outlining the serial multiscale MD workflow. (A) Initial simula-
tion setup. Lipids are randomly distributed throughout the simulation
box. Lipid phosphate headgroups are shown as transparent orange spheres,
while lipid tails, water, and ions are omitted for clarity. (B) Simulation
FIGURE 3 Membrane binding of PTEN. Protein-lipid heavy atom
contacts within 4 A˚ from the atomistic simulations for the wild-type
PTEN protein and (A) a zwitterionic bilayer, and (B) a bilayer containing
20% anionic lipids. The region containing residues R161, K163, and
K164 is expanded in each case. (C and D) Respective contacts mapped
onto the PTEN structure, illustrating the location of the interaction surface
with the lipid bilayer. The region missing from the crystal structure is
shown as a dotted line, and is seen to be distant from the lipid-binding inter-
face. Note that panels A and C are annotated to indicate regions (a–e) of the
sequence that interact most strongly with the lipid bilayer. The main peaks
occur in approximately the same residues for both the zwitterionic and the
20% anionic bilayer. Thus, the largest peaks are for (a) D22, (b) R41 (R47
for the 20% anionic bilayer), (c) R161, (d) K263, and (e) R335.
Biophysical Journal 104(3) 613–621
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membrane interaction of PTEN
Three basic side chains (R161, K163, and K164) of the PD
form a cationic patch on the surface of PTEN. Previously
Das et al. (39) established that mutation of these residues re-
sulted in a decrease in membrane-binding affinity. However,
the mutant retained phosphatase activity, suggesting that
this region did not interact with the substrate PI(3,4,5)P3
directly. To further explore our binding model for PTEN,snapshot after 0.5 ms CG simulation. Bilayer self-assembly and PTEN-
membrane complex formation occurs within the first few tens of nanosec-
onds of simulation in all cases. (C) The final frame of the CG simulation
shown in panel B is converted to an atomistic representation, which is
then simulated for a further 50 ns.
PTEN Simulations 617we simulated a triple mutant (R161E/K163E/K164E) in
which we replaced this cationic patch by an anionic equiv-
alent (Fig. 4). The protein-lipid contacts in this region
between the charge reversal mutant PTEN and the bilayer
are substantially reduced, especially for the anionic PS-
containing lipid bilayer (Fig. 4). Similar behavior was
observed when simulations were run using higher concen-
trations (40%) of anionic lipids, in which case the interac-
tion between the mutant patch and the lipid bilayer was
almost completely abrogated (see Fig. S1). In all cases,
there are markedly fewer contacts between the residues at
positions 161, 163, and 164 and the lipids in the bilayer
upon mutation.
The close correspondence between experiment and simu-
lation in this case suggests that our multiscale model may be
used predictively to examine the effects of mutations on
PTEN-membrane interactions, at least in a qualitative
fashion.FIGURE 5 Anionic lipid association with membrane bound PTEN. The
results of analysis of the frequency of occurrence of anionic (PS) lipid head-
groups in the bilayer (xy) plane adjacent to PTEN based on simulations of
(A) the wild-type and (B) the R161E/K163E/K164E mutant proteins. TheAnionic lipids interact with both of the PTEN
domains
It is of interest to see how PTEN binding may perturb the
bilayer lipid composition local to the protein, particularly
in the context of, for example, studies of lipid nanocluster-
ing adjacent to other classes of membrane proteins (41).
Anionic lipid distributions around PTEN may be visualized
via surface density maps (Fig. 5) and quantified by compu-FIGURE 4 Membrane binding of a mutant PTEN. The electrostatic
potential around (A) the wild-type protein and (B) the R161E/K163E/
K164E mutant protein are shown, calculated using the Adaptive Poisson-
Boltzmann Solver (38). The location of the cationic patch formed by
R161, K163, and K164 is indicated by the dotted line. (C) Protein-lipid
heavy atom contacts within 4 A˚ from the atomistic simulations for the
R161E/K163E/K164E mutant protein and a bilayer containing 20% anionic
lipids. The region containing E161, E163, and E164 is highlighted to facil-
itate comparison with Fig. 3. Electrostatic potential isocontours are shown
at contour values of 1 kT/e (red) to þ1 kT/e (blue).
analysis is derived from the CG MD simulations in the presence of 20%
PS in the bilayer. The color contours show the surface density of lipid head-
groups. For 20% PS in an equilibrated bilayer with even distribution of
lipids one would expect a surface density of ~0.003 A˚2 assuming the
area per lipid for POPS is 55 A˚2 (54). This would correspond to yellow/
green contours in the density maps. The black trace shows the position of
PTEN, used as a reference frame in this analysis, with the PD and C2
domains labeled.tation of radial distribution functions of the anionic lipids in
the cytoplasmic leaflet of the lipid bilayer around the bound
protein (see Fig. S2). It is clear from either analysis that
anionic lipids cluster around both the PD and C2 domains
of PTEN. This behavior is also observed in the simulations
of the R161E/K163E/K164E mutant protein, although the
extent of the PD-associated cluster is reduced. This also
helps to explain the experimental observation that the
membrane-binding affinity of the R161/K163/K164 mutant
is much lower than that of the wild-type despite the fact that
it remains catalytically competent and able to bind to
PI(3,4,5)P3. It has been suggested that the C2 domain of
PTEN is responsible for positioning the PD in an optimal
orientation for binding to PI(3,4,5)P3 (42), and that it
enhances the interaction of the PD with the membrane
(39) possibly by binding to anionic lipids (43,44). This
would correlate with the strong clustering of anionic lipids
around the C2 domain, in both the wild-type and mutant
protein simulations.Biophysical Journal 104(3) 613–621
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interactions
We calculated a PMF to provide a semiquantitative insight
into the thermodynamics of the interaction between PTEN
and a PI(3,4,5)P3-containing lipid bilayer. More specifi-
cally, the PMF provides a one-dimensional view of the
CG free energy landscape along a reaction coordinate cor-
responding to center-of-mass separation between PI(3,4,5)
P3 and PTEN as PTEN is translated along the bilayer
normal.
The global minimum of the PMF (u in Fig. 6) corresponds
to the native location as defined by the CG self-assembly
simulations described above. This is reassuring, as it
demonstrates that the self-assembly procedure correctly
locates the minimum energy configuration of the PTEN-
membrane system. Thus one may compare the system
configuration corresponding to the minimum along the
PMF with the equilibrium (i.e., self-assembly) simulations
by calculating the values of the PTEN-POPC center-of-
mass separations along z. Averaging over three repeats of
the CG MD self-assembly simulations (over 100–500 ns;
i.e., after the bilayer has formed) yields a PTEN-bilayer
separation of 41 5 1 A˚. For the minimum along the free
energy profile the PTEN-bilayer separation is 43 5 2 A˚).
We may also compare the position of the protein relative
to the bilayer predicted by simulations with the results of
recent neutron reflection studies of PTEN-membrane inter-
actions (45). In the experimental studies, the lipid-bilayer
headgroup to protein center-of-mass distance is ~25 A˚. In
CG PMF simulations (configuration u in Fig. 6), the corre-Biophysical Journal 104(3) 613–621sponding distance is ~27 A˚. Given the intrinsic resolution
limits of CG, this is excellent agreement.
More detailed examination of the configurations of the
system corresponding to shoulders in the PMF (v and w in
Fig. 6) suggests that the C2 domain may interact more
tightly with the membrane than does the PD. However, we
are aware that the PMF provides a one-dimensional view
of a more complex energy landscape for PTEN/bilayer inter-
actions, and so this conclusion remains tentative. We have
evaluated the convergence of our (one-dimensional) PMF
(see Fig. S3). This suggests that convergence of a multidi-
mensional PMF (with, for example, both protein separation
and orientation as reaction coordinates) could require
enhanced sampling techniques such as metadynamics (46).Membrane-interacting residues and
disease-causing mutations
To determine whether our model of membrane-bound PTEN
was able to shed any light on mutations implicated in human
cancer,we compared the contacts observed in our simulations
to the disease-causing mutations documented in the Human
GeneMutationDatabase (16).A summary of the PTENmuta-
tions extracted from this database is provided as Table S2.
Many of the oncogenic and disease-causing mutations in
PTEN occur either at the PD:C2 domain interface or
are hydrolysis-defective mutations located at the phospha-
tase active site. However, several mutations occur at loca-
tions spatially distinct from these regions. We identified
N48K (47), R234Q (48), and R335L (49) as potentialFIGURE 6 Potential of mean force (i.e., free
energy profile) along a reaction coordinate defined
by the distance between the PTEN and PI(3,4,5)P3
centers of mass along the bilayer normal (z). This
PMF was evaluated using CG MD simulations
and the bilayer containing 20% PS. The PMF
was calculated over the intervals 400–500 ns for
each window on z: this 100-ns interval was divided
into ten segments each of 10-ns duration (400–410,
410–420 ns, etc.) and the PMF evaluated for each
segment. The resultant ten PMF profiles were
used to calculate a mean profile (red line) and stan-
dard deviations (gray bars), as shown. The
windows at 4 A˚, 10 A˚, and 18 A˚ are labeled along
the PMF by u, v, and w, respectively, and snapshots
from the final frame of each of these windows are
shown on the right of the figure.
PTEN Simulations 619membrane-interacting residues based on our simulations
(Fig. 7). Of these three residues, R335 was observed to
interact with the membrane to the greatest extent across
all of the simulations. R335L, in common with several other
germline mutations, has been associated with the inherited
cancer syndrome Cowden’s disease (50), which results in
higher risk of developing breast and thyroid cancer. The
close proximity of this residue to the membrane in our simu-
lations, coupled with the charged to nonpolar nature of the
mutation, led us to speculate that the oncogenic nature of
the R335L mutant may in part be due to a reduced binding
affinity for anionic lipids.
To examine this, we performed simulations of the R335L
mutant protein with the zwitterionic and 20% anionic lipid
systems, and again analyzed the contacts between the
protein and the lipid bilayer. We observe a modest reduction
in protein-lipid contacts for this region of the protein, with
the protein-lipid interaction originating from the residue at
position 335 in the mutant R335L reduced to just over one
third of that detected in the wild-type in both cases. This
provides some support for our hypothesis that a reduction
in the interaction between the mutant protein and the
membrane contributes to its oncogenicity, though clearly
further studies (both simulation and experiment) to quantify
changes in interactions and clinical effects of mutants are
needed to confirm this.CONCLUSIONS
Using a multiscale simulation approach developed and
tested using a number of simpler membrane proteins, weFIGURE 7 Locations of membrane-interacting clinically important
mutations. Most oncogenic mutants occur at the PD:C2 domain interface
or at the phosphatase active site. A selection of these is shown as yellow
van der Waals spheres. However several mutants occur at sites spatially
separated from these locations. In the PD (pink), N48K is shown in red
and labeled. In the C2 domain (cyan), R234Q and R335L are also shown
in red and labeled. The lipid bilayer is shown as a translucent white surface.have generated a detailed model of the interaction of
PTEN with lipid bilayer membranes. This model correlates
well with experimental data, in particular the correlation of
the predicted lipid-binding surface with the properties of
scanning mutations which perturb lipid binding (39), in
the agreement between the predicted distance of the protein
center of mass from the lipid-bilayer center of mass with
that estimated from neutron reflection experiments (45),
and with structural data (i.e., tartrate binding) on PI(3,4,5)
P3 binding to the protein (17).
Our studies emphasize the importance of both the phos-
phatase and the C2 domain in providing membrane recogni-
tion platforms, in addition to the primary catalytic role of
the phosphatase domain. Binding modes of membrane-
localizing proteins that involve multiple recognition points
have been observed in recent studies of PH domains (25)
and of talin (26). The importance of both the PD and C2
domains in membrane recognition by PTEN agrees with
and extends previous studies on nonspecific electrostatic
recognition of bilayers by C2 domains from PTEN and other
proteins (43).
Our simulations reveal aspects of the complex interrela-
tionships of protein and lipid in the PTEN interactions,
with PTEN binding leading to a degree of nanoclustering
of anionic lipids. This is likely to be a general feature of
binding of membrane recognizing proteins and enzymes,
and as such merits further attention.
Our model adds to the interpretation of clinical muta-
tional data in terms of the structure/function basis of the
underlying mutation. In particular, we are able to show
that a mutation leading to Cowden syndrome (R335L
(50)) results in a significant perturbation of protein-bilayer
interactions.
It is important to consider the likely limitations of this
study. One is the focus on the core PTEN structure and its
interactions with membranes, neglecting the N-terminal
PI(4,5)P2 binding module and the C-terminal tail (neither
of which is present within the x-ray structure). The
N-terminal PI(4,5)P2 binding module is thought to have an
influence in membrane binding (45) and it has been sug-
gested (40) these two regions act in an autoinhibitory
fashion when PTEN is present in the cytosol, by associating
with the membrane binding surfaces of the PD and the C2
domains respectively through electrostatic interactions.
We also acknowledge the simplicity of our lipid bilayer
composition, which is closer to in vitro model bilayers than
those occurring naturally in vivo. In the future it should be
possible to introducemore complexmembrane compositions
including most lipids identified in recent lipidomics studies
(7) to further characterize the membrane-associated state of
PTEN under more physiological conditions. Looking ahead,
themodel described herewill form the basis ofmore complex
and indeedmore realistic computational studies, exploring in
more detail the relationship between membrane binding,
(anionic) lipid recruitment, and catalysis.Biophysical Journal 104(3) 613–621
620 Lumb and SansomThis will in turn enable improvements in models of
PTEN/inhibitor interactions (51). It should also be possible
to extend such models to other membrane proteins using
a PTEN-like domain for bilayer recognition, for example
auxilins (52) and the voltage-sensing phosphatase from
Ciona intestinalis (53).SUPPORTING MATERIAL
Two tables and three figures are available at http://www.biophysj.org/
biophysj/supplemental/S0006-3495(12)05080-1.
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